| Income Statement |
| Total Revenue | 111.08M |
|
| Revenues (USD) | 111.08M |
| Cost of Revenue | 43.38M |
| Gross Profit | 67.70M |
| Operating Expenses | 61.32M |
| Research and Development Expense | 1.11M |
| Selling, General and Administrative Expense | 60.04M |
| Operating Income | 6.37M |
| Interest Expense | 1.13M |
| Income Tax Expense | 2.56M |
| Net Income | 2.40M |
| Net Income Common Stock | 2.40M |
| Net Income Common Stock (USD) | 2.40M |
| Consolidated Income | 2.40M |
| Earnings per Basic Share | 0.03 |
| Earnings per Basic Share (USD) | 0.03 |
| Earnings per Diluted Share | 0.03 |
| Earning Before Interest & Taxes (EBIT) | 6.09M |
| Earning Before Interest & Taxes (USD) | 6.09M |
| Weighted Average Shares | 92.93M |
| Weighted Average Shares Diluted | 94.83M |
| Balance Sheet |
| Cash and Equivalents | 123.78M |
| Cash and Equivalents (USD) | 123.78M |
| Trade and Non-Trade Receivables | 91.76M |
| Current Assets | 262.26M |
| Property, Plant & Equipment Net | 29.31M |
| Total Assets | 384.25M |
| Debt Current | 4.36M |
| Total Debt | 67.53M |
| Current Liabilities | 312.31M |
| Debt Non-Current | 63.18M |
| Total Liabilities | 400.92M |
| Accumulated Retained Earnings (Deficit) | -197.62M |
| Accumulated Other Comprehensive Income | -4.84M |
| Shareholders Equity | -16.67M |
| Shareholders Equity (USD) | -16.67M |
| Assets Non-Current | 121.99M |
| Total Debt (USD) | 67.53M |
| Deferred Revenue | 267.13M |
| Liabilities Non-Current | 88.61M |
| Trade and Non-Trade Payables | 4.58M |
| Tax Assets | 59.11M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.33M |
| Net Cash Flow from Financing | -9.83M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.75M |
| Capital Expenditure | -730.00K |
| Issuance (Purchase) of Equity Shares | 174.00K |
| Issuance (Repayment) of Debt Securities | -10.00M |
| Net Cash Flow from Investing | -730.00K |
| Net Cash Flow from Operations | -1.65M |
| Effect of Exchange Rate Changes on Cash | 3.46M |
| Share Based Compensation | 2.66M |